P2Y12 inhibitor monotherapy soon after PCI for ACS was not noninferior to DAPT for a composite of death or ischemic events. Bates ER. Ann Intern Med 2025;178:JC137.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bates ER. P2Y12 inhibitor monotherapy soon after PCI for ACS was not noninferior to DAPT for a composite of death or ischemic events. Ann Intern Med 2025;178:JC137.
PMID: 41325613